Nexentis Technologies Inc. NXTS 深 滬
已收盤 11-06 16:00:00 美东时间
0.5142
+0.033
+6.79%
華盛通- 最 高0.55
- 今 開0.49
- 成交量 22.92万股
- 最 低 0.4777
- 昨 收 0.4815
- 總市值 74.73万
- 52周最高 23.80
- 市盈率 靜 --
- 換手率 15.77%
- 52周最低 0.428
- 委 比 93.39%
- 總股本 145.33万
- 歷史最高 18865.00
- 量 比 2.13
- 振 幅 15.02%
- 歷史最低 0.428
- 每 手 1
- 風險率 6.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nexentis Announces Reverse Stock Split
Nexentis Technologies Inc. announced a 1-for-5 reverse stock split of its common stock, effective November 9, 2026, to increase its share price and meet Nasdaq listing requirements. The split will reduce outstanding shares from approximately 2.9 million to 600 thousand, with no fractional shares issued. The company also invests in European solar energy projects under its RTB business model.
11-05 14:00
12 Materials Stocks Moving In Monday's After-Market Session
Gainers Apex Critical Metals (NASDAQ:APXC) stock increased by 24.9% to $6.56 during Monday's after-market session. Paramount Gold Nevada (AMEX:PZG) shares moved upwards by 12.54% to $1.05. The company's market cap stands at $78.9 million. Chilwa Minerals (NASDAQ:CHWM) stock increased by 12.08% to $5...
10-27 05:05
Nexentis Technologies' MitoCareX Bio Subsidiary Completes Initial Computational Screening Stage Under Its Drug-Discovery Initiative With Boltz
Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nexentis" or the "Company") today announced that its wholly owned subsidiary, MitoCareX Bio Ltd. ("MitoCareX"), has completed an initial computational screening stage under its drug-discovery initiative with Boltz, PBC ("Boltz"), an AI research lab focused...
10-26 20:18
Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
Nexentis Technologies Inc.'s subsidiary, MitoCareX Bio Ltd., has completed an initial computational screening stage in its drug-discovery initiative with Boltz, an AI research lab. MitoCareX considers the preliminary computational findings encouraging for further analysis and validation. The initiative combines MitoCareX's proprietary capabilities with Boltz's AI models to identify potential small-molecule candidates. Further scientific assessmen...
10-26 12:16
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
MitoCareX Bio, a subsidiary of Nexentis Technologies, is evaluating additional commercially available approaches for obtaining proteins to enhance research capabilities, increase flexibility, and support its in-vitro drug discovery programs. The assessment aims to broaden research tools while maintaining flexibility as discovery programs progress. The evaluation is currently at an early stage, and no assurance is given regarding the adoption or b...
09-23 11:07
Nexentis Technologies Subsidiary MitoCareX Bio Narrows Its SLC Transport Protein Candidates To Select Candidate For A Drug Discovery Campaign
As previously disclosed, MitoCareX's broad structural analysis identified a set of SLC transport proteins outside its mitochondrial program that appeared compatible with the MITOLINE® enabled structural modelling. Building on that work, the Company has now completed an internal prioritization proces...
07-28 20:13
Nexentis Technologies Subsidiary Completes Analysis Of SLC Transport Proteins, Starts Global AI Drug Discovery Initiative With Boltz
Nexentis Technologies Inc. ("Nexentis"), (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, has recently reported that its wholly owned subsidiary, MitoCareX Bio Ltd. ("MitoCareX Bio"), succ...
07-07 20:27
美股夜盘 | Quoin Pharmaceuticals. Ltd Sponsored ADR涨58.15%，LEIFRAS Co涨29.02%
智能充电涨-29.45%；Rubico Inc.涨-15.73%；Cerebras Systems涨-11.98%
06-24 08:05
Crude Oil Down Over 1%; US Manufacturing PMI Surges In June
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 500 points on Tuesday. The Dow traded down 0.04% to 51,694.44 while the NASDAQ fell 1.91% to 25,665.85. The S&P 500 also fell, dropping, 1.27% to 7,377.89. Leading and Lagging Sectors Consumer staples shares ju...
06-24 00:02
Dow Falls Over 300 Points; Korn Ferry Earnings Top Views
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.62% to 51,390.66 while the NASDAQ fell 1.88% to 25,675.75. The S&P 500 also fell, dropping, 1.39% to 7,370.98. Leading and Lagging Sect...
06-23 21:49
